Cargando…
COVID-19 and systemic anticancer therapy: exploiting uncertainty
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836221/ https://www.ncbi.nlm.nih.gov/pubmed/33253642 http://dx.doi.org/10.1016/S1470-2045(20)30700-2 |
| _version_ | 1783642701157105664 |
|---|---|
| author | Gelderblom, Hans Veelken, Hendrik Stiggelbout, Anne M |
| author_facet | Gelderblom, Hans Veelken, Hendrik Stiggelbout, Anne M |
| author_sort | Gelderblom, Hans |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7836221 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78362212021-01-26 COVID-19 and systemic anticancer therapy: exploiting uncertainty Gelderblom, Hans Veelken, Hendrik Stiggelbout, Anne M Lancet Oncol Comment Elsevier Ltd. 2021-01 2020-11-27 /pmc/articles/PMC7836221/ /pubmed/33253642 http://dx.doi.org/10.1016/S1470-2045(20)30700-2 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Gelderblom, Hans Veelken, Hendrik Stiggelbout, Anne M COVID-19 and systemic anticancer therapy: exploiting uncertainty |
| title | COVID-19 and systemic anticancer therapy: exploiting uncertainty |
| title_full | COVID-19 and systemic anticancer therapy: exploiting uncertainty |
| title_fullStr | COVID-19 and systemic anticancer therapy: exploiting uncertainty |
| title_full_unstemmed | COVID-19 and systemic anticancer therapy: exploiting uncertainty |
| title_short | COVID-19 and systemic anticancer therapy: exploiting uncertainty |
| title_sort | covid-19 and systemic anticancer therapy: exploiting uncertainty |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836221/ https://www.ncbi.nlm.nih.gov/pubmed/33253642 http://dx.doi.org/10.1016/S1470-2045(20)30700-2 |
| work_keys_str_mv | AT gelderblomhans covid19andsystemicanticancertherapyexploitinguncertainty AT veelkenhendrik covid19andsystemicanticancertherapyexploitinguncertainty AT stiggelboutannem covid19andsystemicanticancertherapyexploitinguncertainty |